Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asymptomatic HIV Infection”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Large-scale testing (Phase 3)Study completedNCT00000750
What this trial is testing

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Early research (Phase 1)Study completedNCT00002373
What this trial is testing

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56
Not applicableEnded earlyNCT02898896
What this trial is testing

Coronary Artery Disease (CAD) in Suppressed HIV-infected

Who this might be right for
Virus-HIV
University Hospital, Montpellier 62
Testing effectiveness (Phase 2)Ended earlyNCT04840199
What this trial is testing

Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Who this might be right for
HIV InfectionsCytomegalovirusCMV
National Institute of Allergy and Infectious Diseases (NIAID) 44
Early research (Phase 1)Study completedNCT00000664
What this trial is testing

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Early research (Phase 1)Study completedNCT00000667
What this trial is testing

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00000762
What this trial is testing

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Early research (Phase 1)Study completedNCT00002078
What this trial is testing

Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection

Who this might be right for
HIV Infections
Purdue Frederick
Early research (Phase 1)Study completedNCT00002350
What this trial is testing

A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients

Who this might be right for
HIV Infections
Apollon 16
Not applicableEnded earlyNCT00000875
What this trial is testing

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 16
Early research (Phase 1)Study completedNCT02456558
What this trial is testing

Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

Who this might be right for
Asymptomatic HIV Infection
ApoPharma 30
Not applicableStudy completedNCT00973466
What this trial is testing

Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients

Who this might be right for
HIV InfectionsNeisseria GonorrhoeaeChlamydia Trachomatis+1 more
Insel Gruppe AG, University Hospital Bern 300
Not applicableLooking for participantsNCT07312266
What this trial is testing

Questioning the Epidemiology of Asymptomatic TB

Who this might be right for
TuberculosisTuberculosis (TB)HIV+1 more
Barcelona Institute for Global Health 6,770
Not applicableStudy completedNCT00001997
What this trial is testing

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

Who this might be right for
HIV Infections
Chiron Corporation
Testing effectiveness (Phase 2)Study completedNCT00002324
What this trial is testing

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

Who this might be right for
HIV Infections
Boehringer Ingelheim 250
Early research (Phase 1)Study completedNCT02191657
What this trial is testing

Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

Who this might be right for
HIV Infection
ApoPharma 26
Not applicableStudy completedNCT03446677
What this trial is testing

Postural Stability Deficiencies in Asymptomatic Individuals With HIV

Who this might be right for
HIVBalanceVestibular Disorder+2 more
Texas Woman's University 20
Not applicableStudy completedNCT00002323
What this trial is testing

A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell

Who this might be right for
HIV Infections
Boehringer Ingelheim 60
Not applicableStudy completedNCT00002260
What this trial is testing

An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

Who this might be right for
HIV Infections
Lederle Laboratories
Early research (Phase 1)Study completedNCT00917813
What this trial is testing

Anti-HIV Monoclonal Antibody KD-247

Who this might be right for
HIV Infections
The Chemo-Sero-Therapeutic Research Institute 27
Load More Results